New Delhi, 03 Dec 2020:Despite Pharma sales representatives being locked indoors due to COVID-19 outbreak, Rx drug brands reached out to 75% Physicians in their targeted specialties, as per the 100-day Report of Doceree, Physician-only platforms for programmatic marketing.

Pharma marketers were able to get close to 2/3rd of the reach they were getting in the pre-COVID era. Doceree analysed over 20 million impressions served through its platform in the last 100 days from July 2020 – Oct 2020 (Q3 2020) and observed real-time developments in the Physician digital marketing space that could reflect broader trends.

“With COVID, it became difficult for Pharma brands to reach out to doctors. The field force was grounded, events/ conferences/congresses were either cancelled or moved online. In such a scenario, sales force took to tools like Whats App and i-messages to gain access to doctors and used Zoom meetings for remote detailing; but all with very little success as doctors found them intrusive in their professional and personal lives.In that scenario, Pharma marketers found solace in digital. They looked for professional platforms to reach out to doctors in a regulatory-compliant manner,” said Dr. Harshit Jain, Founder & CEO, Doceree.

The report dug deep into the vast amount of data captured by the Doceree platform to provide marketers with key trends and important insights into the Physician digital marketing. The data has been gathered from the digital marketing campaigns that pharmaceutical and healthcare brands run through the platform.

In terms of reach, Delhi & Mumbai provides nearly 10% reach of the overall doctor population. If Delhi-NCR (Central Delhi, Gurgaon, and Faridabad) is considered, then the reach is around 12%. Interestingly, 8 out of top 10 cities that give higher reach are in North India. Doceree provides the ability to precision target Physicians with its unique identity-resolution proprietary technology – Espyian.

The post Rx drug brands reached 75% Physicians even during COVID-19 appeared first on Health Vision.

2. 90% Pharma marketers say non-transparency is a key set-back in digital espousal in Rx drug marketing: Doceree survey. 

3. New Jersey-based Doceree launches AI-enabled dashboard to bring transparency in Pharmaceutical Marketing

November 2, 2020: 90% Pharmaceutical marketers are of the opinion that non-transparency of ‘doctor reach and results’ is a key set-back for implementation of digital in Rx drug marketing, according to the study by Doceree, the foremost global web of Physician-only platforms for programmatic marketing. It is a fact that Pharmaceutical industry hang back on digital espousal in contrast to consumer brands which have seen fabulous growth in digital marketing technologies.

In the past decade, pioneering digital business models aroused in a various fields. Nevertheless, pharmaceutical by and large remained an exemption from entering to digital platforms. The marketing strategies are still limited to conventional ways of doing business and Physician marketing is nowhere close to consumer marketing that grew leaps and bounds after companies in the space shifted to digital methods and made them an vital tool to sweep to their targeted crowd.

“We associate with several digital platforms. But the output are not very pleasing and very often there seems to be discrepancies in the information provided. Deciphering information that are pooled by partner digital platforms is a tough task and data points all the time do not go with the results shared, heading to discrepancy. Thus this non-transparency is a big confront to make use of digital channels,” said a Pharma marketer on circumstance of ambiguity.

Doceree undertook the survey with 500 Pharmaceutical marketers of zenith Rx drug firms, comprising Abbott, Pfizer, Cipla, GSK and Novartis, to know how big uncertain block non-transparency was in digital implementation among Pharma marketers. To solve the enduring issue and nourish trust among Pharma marketers and build the category, Doceree has presented AI-enabled dashboard that provide its clients – pharma brands and media agencies – get information and updates about their strategy in real time.

“Rx drug brands make great pay-outs for promotion on generic digital decks. Though there is no clarity of progress of digital campaigns, thus beating the very intention of using a digital platform. They squander monies on the digital medium to get in touch with Physicians, but are not very certain about the authenticity of output. For Pharma marketers who are already sceptical about digital mediums, the situation has only aggravated further and led to confidence issues. Our AI-enabled dashboard will give full transparency, manage and the aptitude to enhance for better efficiencies. A lot of brands are already channelling all their digital marketing spends through Doceree now,” said Dr. Harshit Jain, Founder & CEO, Doceree.

At a time when digital is achieving a strong grip, Doceree is striving to develop an ecosystem that creates trust among Pharma marketers and aid them to utilise the true prospective of digital platform.

The post Non-transparency a major bottleneck in digital adoption in Pharmaceutical appeared first on Health Vision.

New Delhi, May 12, 2020: Doceree Inc., (www.doceree.com), the world’s first programmatic physician engagement platform, has raised $1 million in seed funding from a group of angel investors from India and the United States. The New Jersey-based Doceree successfully secured the funds despite the unprecedented corona virus crisis that is wreaking havoc on stocks worldwide, causing a meltdown in investment sentiment globally. The health-tech startup plans to utilize the funds for customer acquisition, recruiting talent, scaling up operations in India and the US and ramping up technology to further digitalize physician engagement experience.

The seed funding round was led by Kumar Gaurav, Founder & CEO of Beyond Codes in which other investors from advertising and pharmaceutical industry participated. Doceree, that connects pharma brands and digital platforms and allows products and services of the former to be marketed to physicians on the latter’s platforms, has also inducted Rahul Gupta in the management board. Mr Gupta is a serial investor in over 15 IT, ITES, Healthcare and the Real Estate sector businesses.

Founded in 2019, Doceree aims to address the problem of rising cost of healthcare by bringing efficiency and effectiveness to physician engagement by using data and creativity in healthcare marketing. Dr. Harshit Jain, Founder and CEO, Doceree, who began his career as a healthcare specialist and later turned full-time to healthcare marketing, said Doceree is playing a pivotal role in improving healthcare delivery and outcomes by building brand relationships with healthcare professionals (HCPs) and adding genuine and long-term value to them through data-driven endemic marketing.

“In the healthcare space, there is a huge data that lies underutilized which when used efficiently can drastically change the way physicians are engaged. The challenge is that despite changing dynamics and the surge of digitisation, it’s still hard for pharmaceutical brands to approach physicians on the digital medium. While pharma companies spend a huge amount to market physicians in the traditional way, they are not able to tap the vast potential of the digital medium to grow their businesses. That is the gap Doceree plugs by helping them make the most of the Digital Physician Ecosystem through its Programmatic Physician Engagement Platform,” said Dr. Harshit.

 The company witnessed a massive growth since its launch in the US, being able to create an expansive network of 1 million physicians there in an incredibly short span of time.  After gaining a strong foothold in the US market, Doceree launched its India operations in mid-March this year, having advanced its entry to let pharmaceutical companies gain access to physicians amid corona virus pandemic through its platform for free, in its bid to support them when their crucial workforce of medical and sales representatives are locked indoors.

“Doceree’s concept of programmatic physician engagement is distinct, disruptive and innovative. How it became a crucial tool for pharma companies to reach out to doctors during the ongoing COVID-19 crisis establishes the greater need and importance of the platform. The future of digital access to physicians is very promising and we truly believe in Doceree’s vision,” said Rahul Gupta.

 The company replicated the huge response it received in the US, in India as well. A significant number of renowned pharma brands and digital platforms are already using Doceree platform in both India and the US. Doceree enables pharma companies to market to physicians using technology to automatically serve ads — reaching the right user with the right message at the right time, optimising efficiency i.e. clicks and conversions, reducing waste and ensuring effective measurement of return on investment (RoI).

The post Health tech startup Doceree closes seed funding round of $1 M appeared first on Health Vision.

The post Doceree helps Cos reach doctors amid Corona lockdown. appeared first on Health Vision.